Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Elizabeth S. Klings, MD
Researcher Director, Center for Excellence in Sickle Cell Disease
Boston University School of Medicine
Shapiro Building, Suite 9B
Boston, Massachusetts, United States
Dr. Klings is an Associate Professor in the Department of Medicine. She attends in the Medical Intensive Care Unit and on the Pulmonary Consultation Service at Boston Medical Center. Additionally, she has a clinic in the Pulmonary Hypertension Center at Boston Medical Center where she is involved in the diagnosis, evaluation and treatment of patients with pulmonary hypertension (Pulmonary Hypertension Center). She has special interest in the management of patients with chronic dyspnea and is the former Medical Director of the Pulmonary Rehabilitation Program.
Dr. Klings has clinically phenotyped over 200 adults with sickle cell disease being treated at Boston Medical Center and has utilized genomic and proteomic approaches to understand the pathogenesis for pulmonary vascular disease in this population.
Her current research interests surround understanding the role of sleep-disordered breathing, chronic intermittent hypoxia and thrombosis as pulmonary vascular modulators in sickle cell disease.
Special Interests:
Research:
– Pulmonary complications of sickle cell disease
– Role of genetic modulation in pulmonary hypertension of sickle cell disease
Clinical:
– Pulmonary Hypertension
– Pulmonary Complications of Sickle Cell Disease
– Critical Care Medicine
– Pulmonary Rehabilitation
Representative Publications:
Prostacyclin-analog therapy in sickle cell pulmonary hypertension
Chronic Pulmonary Complications of Sickle Cell Disease
Clinical and Laboratory Findings Associated with Sleep Disordered Breathing in Sickle Cell Disease
Sickle cell disease: wheeze or asthma?
Management of patients with sickle cell disease
Related Content
-
Rita Paschal, MDDr. Paschal is Associate Professor of me...
-
Sam Rodgers-Melnick, MT-BCSamuel Rodgers-Melnick, MT-BC is a music...
-
California Institute For Regenerative Medicine Awards City Of Hope $5.74 Million For Severe Sickle Cell Disease Clin...The California Institute for Regenerativ...
-
Access to Care for Individuals With Sickle Cell Anemia – SCDAASickle cell disease (SCD) is a genetic b...
-
Patients With Sickle Cell Disease may Have Lower Risk for C. DifficileFindings from a retrospective cohort stu...
-
A survey of sickle cell patients transitioned to adult care from Texas children’s hematology center between Januar...An estimated 93-98% of sickle cell disea...
-
UC Davis Health, Department of PediatricsThe Section of Pediatric Hematology/Onco...
+myBinder